Drug Type Small molecule drug |
Synonyms GST HG121 |
Target |
Action inhibitors |
Mechanism L-HBsAg inhibitors(L-HBsAg inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 1 | China | 21 Jul 2022 |